KT
King Therapeutics LLC
SEC filingOther · Phoenix, AZ
Amount raised$310Ksold at filing
Total offering$500K$190K still open
Investors in the raise7count reported to the SEC
FiledOct 15, 2025first sale Jun 11, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David RichardsonExecutive Officer, Director
Isaiah SlemonsDirector
Dmitry DerkachDirector
Executive officers, directors and promoters as listed on the Form D.